Loading…
Loading…
BGNE (BeiGene, Ltd.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference, not a current-day signal.
| ROIVROIVRoivant Sciences Ltd. | Roivant Sciences Ltd. | $36.91 | $26.7B |
| ABMDABMDAbiomed, Inc. | Abiomed, Inc. | $381.02 | $17.2B |
| KRTXKRTXKaruna Therapeutics, Inc. | Karuna Therapeutics, Inc. | $329.83 | $12.6B |
| RXDXRXDXPrometheus Biosciences, Inc. | Prometheus Biosciences, Inc. | $199.92 | $9.6B |
| BPMCBPMCBlueprint Medicines Corporation | Blueprint Medicines Corporation | $129.46 | $8.4B |
| CERECERECerevel Therapeutics Holdings, Inc. | Cerevel Therapeutics Holdings, Inc. | $44.96 | $8.2B |
| ISEEISEEIVERIC bio, Inc. | IVERIC bio, Inc. | $39.95 | $5.5B |
| SWTXSWTXSpringWorks Therapeutics, Inc. | SpringWorks Therapeutics, Inc. | $46.99 | $3.5B |
| DICEDICEDICE Therapeutics, Inc. | DICE Therapeutics, Inc. | $47.55 | $2.3B |
| DNADNAGinkgo Bioworks Holdings, Inc. | Ginkgo Bioworks Holdings, Inc. | $12.43 | $837.0M |